Pierre Lo Triozzi

Cleveland Clinic Taussig Cancer Institute, ...Cleveland, Ohio - 44195 (216-445-9567) Cleveland ClinicCleveland, Ohio - 44195 (216-445-9243) |
- CLINICAL TRIALS 2
- CONDITIONS3
- INTERVENTIONS4
- SINCE2007

Dacarbazine and Recombinant Interferon Alfa-2b in Treating Patients With Primary Uveal Melanoma With Genetic Imbalance
November 2009 - January 2013

A Phase I Study to Assess the Safety and Distribution of GT-111 in Patients With Advanced Metastatic Cancer
November 2007 - September 2008
Neoplasm Metastasis
Melanoma
Eye Neoplasms
Laboratory Biomarker Analysis
Dacarbazine
Recombinant Interferon Alfa-2b
Gt-111



